Inositol 1,4,5-triphosphate-associated cGMP kinase substrate: Basis Sequence: Mouse
Sarabeth M Graham1, Sandra Longoria2, Pabak Sarkar3
1Integrative Physiology, UNTHSC, TX 76107, US.
Summary
Inositol 1, 4, 5-trisphosphate (IP3) receptor associated cyclic GMP (cGMP) kinase substrate (IRAG) is a key protein regulating smooth muscle tone and platelet aggregation. Its altered expression suggests roles in pancreatic cancer and cell differentiation.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Inositol 1, 4, 5-trisphosphate (IP3) receptor associated cyclic GMP (cGMP) kinase substrate (IRAG, also known as Mrv1) is an integral endoplasmic reticulum (ER) membrane protein.
- IRAG interacts with IP3 Receptor type 1 (IP3R1) and cGMP kinase I-β (cGKI β), playing a crucial role in cellular signaling pathways.
Purpose of the Study:
- To elucidate the function of IRAG (Mrv1) in regulating IP3R1 activity and smooth muscle physiology.
- To investigate the potential involvement of IRAG in tumorigenesis and cell differentiation processes.
Main Methods:
- The study likely involved molecular biology techniques to analyze protein interactions and expression levels.
- Functional assays were probably used to assess the impact of IRAG on IP3R1 activity, smooth muscle tone, and platelet aggregation.
Main Results:
- IRAG mediates the inhibition of IP3R1 activity via the NO/cGMP/cGKI β pathway, leading to smooth muscle relaxation and inhibition of platelet aggregation.
- IRAG functions as a scaffolding protein, maintaining the integrity and efficiency of protein complexes involving cGKI β and IP3R1.
- Increased IRAG expression in pancreatic cancer cells, independent of tumor-related transcription factors, suggests a role in tumorigenesis.
- Downregulation of IRAG during megakaryocyte maturation points to its involvement in cell growth and differentiation.
Conclusions:
- IRAG is a critical regulator of vascular and platelet function through its interaction with the IP3R1 signaling pathway.
- The study highlights IRAG's dual role, implicating it in both physiological processes and pathological conditions like cancer and developmental pathways.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
9.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.3K
IP3/DAG Signaling Pathway
16.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
16.0K
Calmodulin-dependent Signaling
7.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.1K
Phosphoinositides and PIPs
10.7K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.7K


